Chromoendoscopy Is Better: So Why Am I Not (yet) Using it for Routine Inflammatory Bowel Disease Surveillance?

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 5, 2016, Pages 720-722

  Ananthakrishnan, Ashwin N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDIGO CARMINE; METHYLENE BLUE;

CHROMOENDOSCOPY; COLON ADENOCARCINOMA; COLON ADENOMA; COLON BIOPSY; COLON CROHN DISEASE; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; DISEASE SURVEILLANCE; EDITORIAL; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERMETHOD COMPARISON; NARROW BAND IMAGING; ULCERATIVE COLITIS; WHITE LIGHT ENDOSCOPY; COLORECTAL TUMOR;

COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84949471524     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.09.016     Document Type: Editorial

References (15)

1. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
2. Castano-Milla C., Chaparro M., Gisbert J.P. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis. Aliment Pharmacol Ther 2014, 39:645-659.
3. Awais D., Siegel C.A., Higgins P.D. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity. Gut 2009, 58:1498-1503.
4. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
5. Marion J.F., Waye J.D., Present D.H., et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008, 103:2342-2349.
6. Rutter M.D., Saunders B.P., Schofield G., et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53:256-260.
7. Subramanian V., Mannath J., Ragunath K., et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:304-312.
8. Marion J.F., Waye J.D., Israel Y., et al. Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis. Clin Gastroenterol Hepatol 2016, 14:713-719.
9. Gasia M.F., Ghosh S., Panaccione R., et al. Targeted biopsies identify larger proportions of patients with colonic neoplasia undergoing high-definition colonoscopy, dye chromoendoscopy, or electronic virtual chromoendoscopy. Clin Gastroenterol Hepatol 2016, 14:704-712.
10. Mowat C., Cole A., Windsor A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60:571-607.
11. Van Assche G., Dignass A., Bokemeyer B., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013, 7:1-33.
12. Laine L., Kaltenbach T., Barkun A., et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015, 148:639-651 e28.
13. Mooiweer E., van der Meulen-de Jong A.E., Ponsioen C.Y., et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol 2015, 110:1014-1021.
14. Ignjatovic A., East J.E., Subramanian V., et al. Narrow band imaging for detection of dysplasia in colitis: a randomized controlled trial. Am J Gastroenterol 2012, 107:885-890.
15. Bernstein C.N., Shanahan F., Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 1994, 343:71-74.